These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12185890)

  • 1. Study control, violators, inclusion criteria and defining explanatory and pragmatic trials.
    McMahon AD
    Stat Med; 2002 May; 21(10):1365-76. PubMed ID: 12185890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.
    Godwin M; Ruhland L; Casson I; MacDonald S; Delva D; Birtwhistle R; Lam M; Seguin R
    BMC Med Res Methodol; 2003 Dec; 3():28. PubMed ID: 14690550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Roaming through methodology. XII. Pragmatic and pathophysiologic trials: a question of goal formulation].
    Algra A; van der Graaf Y
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):514-7. PubMed ID: 10321260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pragmatic clinical trials.
    Macpherson H
    Complement Ther Med; 2004; 12(2-3):136-40. PubMed ID: 15561524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intention-to-treat analyses for incomplete repeated measures data.
    Hogan JW; Laird NM
    Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Explanatory clinical trials and pragmatic clinical trials on clinical effective evaluation of acupuncture].
    Wang YJ; Guo YM; Guo Y
    Zhongguo Zhen Jiu; 2010 Jun; 30(6):509-12. PubMed ID: 20578393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of studies of treatments for hand eczema-the EDEN hand eczema survey.
    Van Coevorden AM; Coenraads PJ; Svensson A; Bavinck JN; Diepgen TL; Naldi L; Elsner P; Williams HC;
    Br J Dermatol; 2004 Aug; 151(2):446-51. PubMed ID: 15327553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple and valid tool distinguished efficacy from effectiveness studies.
    Gartlehner G; Hansen RA; Nissman D; Lohr KN; Carey TS
    J Clin Epidemiol; 2006 Oct; 59(10):1040-8. PubMed ID: 16980143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intention-to-treat analysis: who is in? Who is out?
    Kruse RL; Alper BS; Reust C; Stevermer JJ; Shannon S; Williams RH
    J Fam Pract; 2002 Nov; 51(11):969-71. PubMed ID: 12485553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials.
    Yuen SY; Pope JE
    Rheumatology (Oxford); 2008 Sep; 47(9):1367-72. PubMed ID: 18577549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for randomized controlled trials and for intention-to-treat analysis in transfusion medicine: are they one and the same?
    Vamvakas EC
    Vox Sang; 2008 Oct; 95(3):165-73. PubMed ID: 19121180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better conduct of clinical trials: the control group in critical care trials.
    Takala J
    Crit Care Med; 2009 Jan; 37(1 Suppl):S80-90. PubMed ID: 19104230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new 'mechanistic-practical" framework for designing and interpreting randomized trials.
    Karanicolas PJ; Montori VM; Devereaux PJ; Schünemann H; Guyatt GH
    J Clin Epidemiol; 2009 May; 62(5):479-84. PubMed ID: 18468856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria.
    Kingsley GH; Khoshaba B; Smith CM; Choy EH; Scott DL
    Rheumatology (Oxford); 2005 May; 44(5):629-32. PubMed ID: 15705630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redefining the randomized controlled trial in the context of acupuncture research.
    Walji R; Boon H
    Complement Ther Clin Pract; 2006 May; 12(2):91-6. PubMed ID: 16648085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of exclusion criteria in antidepressant clinical trials: a replication study.
    Zetin M; Hoepner CT
    J Clin Psychopharmacol; 2007 Jun; 27(3):295-301. PubMed ID: 17502778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.